Impact of positive airway pressure among obstructive sleep apnea patients

American Journal of Managed Care

Volumn 18, Issue 6, 2012, Pages

  Cai, Qian ^a   Tan, Hiangkiat ^a   Singer, Joseph ^a  

^a HEALTHCORE INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; FEMALE; HEALTH CARE COST; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SLEEP APNEA SYNDROME;

CONFIDENCE INTERVALS; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; INSURANCE CLAIM REVIEW; MONTE CARLO METHOD; MULTIVARIATE ANALYSIS; ODDS RATIO; POLYSOMNOGRAPHY; RETROSPECTIVE STUDIES; RISK; SLEEP APNEA, OBSTRUCTIVE; UNITED STATES;

EID: 84864414055     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc. 2008;5(2):136-143. (Pubitemid 351237871)
2. Kapur VK. Obstructive sleep apnea: diagnosis, epidemiology, and economics. Respir Care. 2010;55(9):1155-1167. on sleep apnea in men, I: prevalence and severity. Am J Respir Crit Care Med. 1998;157(1):144-148.
3. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med. 2002;165(9):1217-1239. (Pubitemid 34461732)
4. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328(17):1230-1235. (Pubitemid 23115702)
5. Bixler EO, Vgontzas AN, Lin HM, et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med. 2001; 163(3, pt 1):608-613. (Pubitemid 32230817)
6. Epstein LJ, Kristo D, Strollo PJ Jr, et al Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep Medicine. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009;5(3):263-276.
7. Harvard Medical School Division of Sleep Medicine. The Price of Fatigue: The Surprising Economic Costs of Unmanaged Sleep Apnea. http://sleep.med. harvard.edu/what-we-do/public-policy-research. Accessed June 1, 2011.
8. Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J. Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. Am J Respir Crit Care Med. 2002;166(2): 159-165. (Pubitemid 34765451)
9. Pagel JF. Obstructive sleep apnea (OSA) in primary care: evidencebased practice. J Am Board Fam Med. 2007;20(4):392-398. (Pubitemid 47173853)
10. Young T, Evans L, Finn L, Palta M. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep. 1997;20:705-706. (Pubitemid 27506200)
11. Nieto FJ, Young TB, Lind BK, et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study: Sleep Heart Health Study [published correction appears in JAMA. 2002;288(16):1985]. JAMA. 2000;283(14):1829-1836. (Pubitemid 30207619)
12. Richert A, Ansarin K, Baran AS. Sleep apnea and hypertension: pathophysiologic mechanisms. Semin Nephrol. 2002;22(1):71-77. (Pubitemid 34076057)
13. Smith R, Ronald J, Delaive K, Walld R, Manfreda J, Kryger MH. What are obstructive sleep apnea patients being treated for prior to this diagnosis? Chest. 2002;121(1):164-172. (Pubitemid 34114242)
14. Chobanian AV, Bakris GL, Black HR, et al National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report [published correction appears in JAMA. 2003;290(2):197]. JAMA. 2003;289(19):2560-2572. (Pubitemid 37430158)
15. Gottlieb DJ, Yenokyan G, Newman AB, et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation. 2010;122(4):352-360.
16. Horstmann S, Hess CW, Bassetti C, Gugger M, Mathis J. Sleepiness-related accidents in sleep apnea patients. Sleep. 2000;23(3): 383-389. (Pubitemid 30263171)
17. Indications and standards for cardiopulmonary sleep studies. American Thoracic Society. Medical Section of the American Lung Association. Am Rev Respir Dis. 1989;139(2):559-568.
18. Practice parameters for the use of portable recording in the assessment of obstructive sleep apnea. Standards of Practice Committee of the American Sleep Disorders Association. Sleep. 1994;17(4):372-377.
19. Practice parameters for the indications for polysomnography and related procedures. Polysomnography Task Force, American Sleep Disorders Association Standards of Practice Committee. Sleep. 1997;20(6):406-422.
20. Calleja JM, Esnaola S, Rubio R, Duran J. Comparison of a cardiorespiratory device versus polysomnography for diagnosis of sleep apnoea. Eur Respir J. 2002;20(6):1505-1510. (Pubitemid 35460621)
21. Redline S, Tosteson T, Boucher MA, Millman RP. Measurement of sleep-related breathing disturbances in epidemiologic studies. Assessment of the validity and reproducibility of a portable monitoring device. Chest. 1991;100(5):1281-1286.
22. Montserrat JM, Alarcón A, Lloberes P, Ballester E, Fornas C, Rodriguez- Roisin R. Adequacy of prescribing nasal continuous positive airway pressure therapy for the sleep apnoea/hypopnoea syndrome on the basis of night time respiratory recording variables. Thorax. 1995;50(9):969-971.
23. Chediak AD. Why CMS approved home sleep testing for CPAP coverage. J Clin Sleep Med. 2008;4(1):16-18. (Pubitemid 352038665)
24. National Institute of Health and Clinical Excellence. Continuous Positive Airway Pressure for the Treatment of Obstructive Sleep Apnoea/Hypopnoea Syndrome. Issue date: March 2008. Review date: November 2010. NICE technology appraisal guidance 139. http://www.nice.org.uk/nicemedia/pdf/TA139Guidance.pdf. Accessed April 15, 2011.
25. Kapur V, Blough DK, Sandblom RE, et al. The medical cost of undiagnosed sleep apnea. Sleep. 1999;22(6):749-755. (Pubitemid 29445342)
26. Ronald J, Delaive K, Roos L, Manfreda J, Bahammam A, Kryger MH. Health care utilization in the 10 years prior to diagnosis in obstructive sleep apnea syndrome patients. Sleep. 1999;22(2):225-229. (Pubitemid 29143221)
27. Kushida CA, Littner MR, Hirshkowitz M, et al American Academy of Sleep Medicine. Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep. 2006;29(3):375-380. (Pubitemid 44019961)
28. Peker Y, Hedner J, Johansson A, Bende M. Reduced hospitalization with cardiovascular and pulmonary disease in obstructive sleep apnea patients on nasal CPAP treatment. Sleep. 1997;20(8):645-653. (Pubitemid 27449604)
29. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-619.
30. Babu AR, Herdegen J, Fogelfeld L, Shott S, Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med. 2005;165(4):447-452. (Pubitemid 40280202)
31. Goncalves MA, Guilleminault C, Ramos E, Palha A, Paiva T. Erectile dysfunction, obstructive sleep apnea syndrome and nasal CPAP treatment. Sleep Med. 2005;6(4):333-339. (Pubitemid 40867824)
32. Centers for Disease Control and Prevention. Chronic Diseases. The Power to Prevent, The Call to Control: At A Glance 2009. http://www.cdc.gov/ chronicdisease/resources/publications/AAG/chronic.htm. Accessed July 2, 2011.
33. Engleman HM, Martin SE, Douglas NJ. Compliance with CPAP therapy in patients with the sleep apnoea/hypopnoea syndrome. Thorax. 1994;49(3):263-266. (Pubitemid 24117454)
34. Hoy CJ, Vennelle M, Kingshott RN, Engleman HM, Douglas NJ. Can intensive support improve continuous positive airway pressure use in patients with the sleep apnea/hypopnea syndrome? Am J Respir Crit Care Med. 1999;159(4, pt 1):1096-1100. (Pubitemid 29202541)
35. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218-1224. (Pubitemid 38579798)
36. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521-530. (Pubitemid 40847288)
37. Tan H, Cai Q, Agarwal S, Stephenson JJ, Kamat S. Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis. Adv Ther. 2011;28(1): 51-61.
38. Pittman DG, Chen W, Bowlin SJ, Foody JM. Adherence to statins, subsequent healthcare costs, and cardiovascular hospitalizations. Am J Cardiol. 2011;107(11):1662-1666.
39. Chervin RD, Theut S, Bassetti C, Aldrich MS. Compliance with nasal CPAP can be improved by simple interventions. Sleep. 1997;20(4): 284-289. (Pubitemid 27276643)
40. Stepnowsky CJ Jr, Bardwell WA, Moore PJ, Ancoli-Israel S, Dimsdale JE. Psychologic correlates of compliance with continuous positive airway pressure. Sleep. 2002;25(7):758-762. (Pubitemid 35216091)
41. Massie CA, Hart RW, Peralez K, Richards GN. Effects of humidification on nasal symptoms and compliance in sleep apnea patients using continuous positive airway pressure. Chest. 1999;116(2):403-408. (Pubitemid 29382125)
42. Pepin JL, Krieger J, Rodenstein D, et al. Effective compliance during the first 3 months of continuous positive airway pressure: a European prospective study of 121 patients. Am J Respir Crit Care Med. 1999;160(4):1124-1129. (Pubitemid 29487449)
43. Sin DD, Mayers I, Man GC, Pawluk L. Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea: a population-based study. Chest. 2002;121(2):430-435. (Pubitemid 34132979)
44. Bahammam A, Delaive K, Ronald J, Manfreda J, Roos L, Kryger MH. Health care utilization in males with obstructive sleep apnea syndrome two years after diagnosis and treatment. Sleep. 1999;22(6): 740-747. (Pubitemid 29445341)
45. Bahammam AS, Tate R, Manfreda J, Kryger MH. Upper airway resistance syndrome: effect of nasal dilation, sleep stage, and sleep position. Sleep. 1999;22:592-598. (Pubitemid 29379116)